Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Wasatch

Wasatch Long/Short Alpha Fund Investor Class Shares (WALSX)

Ticker WALSX · Since 2021-10-01 · · Holdings as of Jun 30, 2026

Expense ratio
2.1%$210/yr per $10k
1-yr return
−12.8%as of Dec 2025
Net assets
$38.4Mall share classes
Holdings
110

Bottom line

Is WALSX a good fund? The bottom line

WALSX is the Investor Class share class of Wasatch Long/Short Alpha Fund, a managed large blend mutual fund from Wasatch.

It charges 2.1% — about $210 a year on every $10,000 invested, more expensive than 94% of large blend funds we track.

It returned −12.8% over one year (as of Dec 31, 2025, per its prospectus).

With $38.4 million in net assets and 110 holdings, its largest position is HealthEquity Inc (5.5%) and the top 10 make up 43.2% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (2.1%)
  • Small fund ($38.4 million) — small funds are likelier to close

Updated Nov 19, 2026

What WALSX invests in

The Funds primary investment objective is long-term growth of capital.

The Fund invests primarily in long equity positions and short equity positions. The Fund seeks to provide higher risk-adjusted returns with lower volatility compared to domestic equity markets. Under normal market conditions, the Fund will establish long and short positions in a portfolio of equity securities, typically common stock, of companies of all market capitalizations. The Fund seeks to take long positions in companies the Advisor believes have the potential for above average revenue and earnings growth. The Fund may also take long positions in companies the Advisor believes are overly discounted. The Funds long positions are intended to benefit from rising valuations while the Funds short positions are intended to benefit from declining valuations or as a hedge against its long positions. The equity securities in which the Fund may invest include common stock, preferred stock…

From the fund's prospectus (filed Jan 28, 2026).

WALSX performance

Fund calendar-year total returns, 2022–2025 2022: −8.4%; 2023: +27.8%; 2024: +7.2%; 2025: −12.8% −8.4% 2022 +27.8% 2023 +7.2% 2024 −12.8% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
WALSX−12.8%——
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full WALSX performance history →

What WALSX costs

On a $10,000 investment, WALSX's 2.1% expense ratio costs about $210 a year. The prospectus estimates $2,431 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full WALSX fee table →

WALSX top 10 holdings

#Holding% of fund
1HealthEquity Inc5.50%
2JFrog Ltd4.61%
3Kadant Inc4.51%
4RBC Bearings Inc4.40%
5Casella Waste Systems Inc4.38%
6UL Solutions Inc4.20%
7Medpace Holdings Inc4.14%
8Allison Transmission Holdings Inc3.91%
9Ensign Group Inc/The3.77%
10Global-e Online Ltd3.75%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 43.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to WALSX

More funds like WALSX →

WALSX FAQ

What is the expense ratio of WALSX?
WALSX's expense ratio is 2.1%, which works out to about $210 a year for every $10,000 invested. The prospectus estimates total costs of $2,431 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is WALSX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (2.1%); small fund ($38.4 million) — small funds are likelier to close. This is general information, not personalized advice.
What does WALSX hold?
WALSX's largest holdings are HealthEquity Inc (5.5%), JFrog Ltd (4.6%), Kadant Inc (4.5%), RBC Bearings Inc (4.4%), Casella Waste Systems Inc (4.4%). It holds 110 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Does WALSX have a sales load?
No. WALSX has no front-end sales charge.
Who manages WALSX?
WALSX is offered by Wasatch through Wasatch Funds Trust.